ResearcherUniversity of TurinActive in the last 2 years

Giorgia Tiberi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5033069395. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinoma. Co-author DOI 10.1002/ctm2.70442 ↗
Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer. Co-author DOI 10.3390/ijms25031389 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paola Cappello · 2 shared papers, 2024–2025 · strength 0.40
- Paper Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer. DOI 10.3390/ijms25031389 ↗
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442 ↗
Marco Erreni · 1 shared paper, 2024 · strength 0.20
- Paper Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer. DOI 10.3390/ijms25031389 ↗
Federica Marchesi · 1 shared paper, 2024 · strength 0.20
- Paper Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer. DOI 10.3390/ijms25031389 ↗
Andrea Doni · 1 shared paper, 2024 · strength 0.20
- Paper Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer. DOI 10.3390/ijms25031389 ↗
Claudia Curcio · 1 shared paper, 2025 · strength 0.20
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442 ↗
Cecilia Roux · 1 shared paper, 2025 · strength 0.20
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442 ↗
Gianluca Mucciolo · 1 shared paper, 2025 · strength 0.20
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442 ↗
Giulia Adriani · 1 shared paper, 2025 · strength 0.20
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442 ↗
Silvia Brugiapaglia · 1 shared paper, 2025 · strength 0.20
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442 ↗
Francesco Novelli · 1 shared paper, 2025 · strength 0.20
- Paper The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenoc… DOI 10.1002/ctm2.70442 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.